Sourasky Medical Center (Ichilov)
| イスラエル | トルコ | オーストリア | |
| 乳癌化学療法 | から $22,500 | から $1,200 | から $15,000 |
| 大腸癌に対する放射線療法 | - | から $7,000 | から $12,000 |
ペレス・シャロン医師は、SIRT療法や肝切除などの高度な技術を含む複雑な肝癌治療を専門とし、スーラスキー医療センターに勤務しています。
メリムスキー教授は、イスラエル屈指のがん治療病院であるスーラスキー医療センターにて、軟部組織・骨腫瘍科を率いています。
この医師は、消化管腫瘍の治療において30年以上の経験を持つ、著名な消化器専門医です。GIがんの予防、早期診断、および治療を専門としており、Sourasky Medical CenterのCancer Prevention Centerを率いています。
ヘブライ大学で一般医学の学位を取得し、テルアビブ大学で消化器学の専門を修了したこの医師は、NewYork-Presbyterian Centerで研究を行いました。この医師は300以上の論文を発表しており、American Association for Cancer ResearchやEuropean Society of Digestive Oncologyを含む、いくつかの著名な組織のメンバーです。
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.
Stage 2 liver cancer is curable in Israel through surgical resection or transplantation for eligible patients. Success hinges on tumor resectability and healthy liver function. Israeli centers like Sourasky Medical Center report oncology treatment success rates reaching 90% for early-staged localized tumors.
Bookimed Expert Insight: Israeli medical centers often utilize advanced robotic systems for liver resections to minimize recovery times. Dr. Ido Nachmany at Sheba Medical Center pioneered robotic resections in the region. Patients should note that Sheba treates over 2 million individuals annually. This high volume often leads to better outcomes in complex hepatopancreatobiliary surgeries.
Patient Consensus: Patients emphasize that surgery offers the best chance for long-term control rather than a guaranteed cure. They suggest ensuring a hepatobiliary surgeon confirms the tumor is resectable with clear margins before traveling.
Non-surgical focal therapies in Israel include radiofrequency ablation, microwave ablation, and NanoKnife irreversible electroporation. These minimally invasive techniques destroy stage 2 liver tumors without large incisions. Specialist centers in Tel Aviv and Haifa utilize advanced imaging to target lesions while preserving surrounding healthy liver tissue.
Bookimed Expert Insight: Israeli oncology centers like Sheba and Sourasky differentiate through specialization. Dr. Almog Ben Yaacov at Sheba Medical Center is specifically trained in both NanoKnife and microwave ablation. This dual expertise is vital because microwave ablation treats larger zones faster. NanoKnife is safer for tumors near blood vessels. Choosing a doctor with multiple certifications ensures the technology matches the tumor anatomy perfectly.
Patient Consensus: Patients note it is essential to have an interventional radiologist review scans rather than just a surgeon. They often mention that combined plans, like using embolization before ablation, can successfully shrink tumors that were initially too large for focal therapy.
Selective Internal Radiation Therapy (SIRT) is used for Stage 2 liver cancer to treat tumors unresponsive to surgery. It involves delivering radioactive Y-90 microspheres directly to the liver via interventional radiology. Procedures are performed at JCI-accredited centers in Israel including Sheba and Sourasky.
Bookimed Expert Insight: Israeli oncology centers often integrate SIRT into complex cases that would be rejected elsewhere. Sourasky Medical Center maintains a 90% oncology success rate through specialized units. Large institutions like Sheba Medical Center handle over 1,900,000 patients annually. This high volume allows doctors to refine criteria for SIRT in early-stage patients. Choosing a facility with over 30,000 operations yearly ensures access to the latest mapping angiogram protocols.
Patient Consensus: Patients note that SIRT is often introduced after a tumor board review when surgery is not straightforward. While recovery can involve fatigue and nausea, many appreciate having an effective option for liver-directed therapy.
Israel's top-rated hospitals for liver cancer include Sourasky Medical Center, Sheba Medical Center, and Hadassah Medical Center. These JCI-accredited facilities provide advanced hepatobiliary surgery and SIRT therapy. They utilize multidisciplinary tumor boards to customize treatment plans for complex oncology cases at every stage.
Bookimed Expert Insight: While many choose hospitals by general reputation, Sheba Medical Center stands out for surgical volume. Dr. Ido Nachmany at Sheba performed Israel's first robotic oncologic resections for the stomach and pancreas. High surgical volumes at such major academic centers often correlate with better outcomes in complex liver resections.
Patient Consensus: Patients emphasize the importance of having imaging re-reviewed by a liver specialist. They also recommend confirming the center provides resections, ablations, and embolization all under one roof.
Israel's leading specialists for liver cancer include Professor Ido Wolf and Dr. Pelles Sharon at Sourasky Medical Center. Top surgeons like Professor Ido Nachmany at Sheba Medical Center specialize in robotic hepatectomies. These experts operate within JCI-accredited facilities using advanced Selective Internal Radiation Therapy (SIRT) protocols.
Bookimed Expert Insight: Data shows a high concentration of Forbes-listed doctors at Sheba and Hadassah. These centers manage over 1,000,000 patients yearly. Specialist Dr. Yuri Goldes and Professor Ido Nachmany both pioneered robotic liver resections. This suggests patients seeking stage 2 treatment should check if robotic options are available for faster recovery.
Patient Consensus: Patients note that choosing dedicated hepatobiliary surgeons leads to better outcomes than general oncologists. Many emphasize seeking centers with liver transplant programs for the most advanced expertise.